CD4 and myeloid sarcoma: In line with earlier findings by Graves et al.[13] and Maltby et al.,[20] we confirmed that HLA-DRB1 is hypomethylated in the CD4+ T cells of MS patients and observed the DMR for the first time in CD8+ T cells.